# ROLE OF FOLIC ACID IN THE MANAGEMENT OF ADJUVANT ENDOCRINE THERAPY-INDUCED HOT FLASHES IN BREAST CANCER PATIENTS

> **NCT06774885** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Future University in Egypt** · enrollment: 120 (estimated)

## Conditions studied

- THERAPY-INDUCED HOT FLASHES IN BREAST CANCER PATIENTS

## Interventions

- **DRUG:** Folic Acid 1 Mg Oral Tablet
- **DRUG:** Folic Acid 5 Mg Oral Tablet

## Key facts

- **NCT ID:** NCT06774885
- **Lead sponsor:** Future University in Egypt
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-02-09
- **Primary completion:** 2025-08
- **Final completion:** 2025-08
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2025-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06774885

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06774885, "ROLE OF FOLIC ACID IN THE MANAGEMENT OF ADJUVANT ENDOCRINE THERAPY-INDUCED HOT FLASHES IN BREAST CANCER PATIENTS". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06774885. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*